AKAP12 Mediates Barrier Functions of Fibrotic Scars during CNS Repair

• Jong-Ho Cha,

  Affiliation SNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea

  ⨯
• Hee-Jun Wee,

  Affiliation SNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea

  ⨯
• Ji Hae Seo,

  Affiliations SNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea, Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Bum Ju Ahn,

  Affiliation SNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea

  ⨯
• Ji-Hyeon Park,

  Affiliation SNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea

  ⨯
• Jun-Mo Yang,

  Affiliation SNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea

  ⨯
• Sae-Won Lee,

  Affiliation Department of Internal Medicine, and Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul, Korea

  ⨯
• Eun Hee Kim,

  Affiliations Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea, Severance Integrative Research Institute for Cerebral & Cardiovascular Disease, Yonsei University College of Medicine, Seoul, Korea, Department of Neurology, Yonsei University College of Medicine, Seoul, Korea

  ⨯
• Ok-Hee Lee,

  Affiliation Severance Integrative Research Institute for Cerebral & Cardiovascular Disease, Yonsei University College of Medicine, Seoul, Korea

  ⨯
• Ji Hoe Heo,

  Affiliations Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea, Severance Integrative Research Institute for Cerebral & Cardiovascular Disease, Yonsei University College of Medicine, Seoul, Korea, Department of Neurology, Yonsei University College of Medicine, Seoul, Korea

  ⨯
• Hyo-Jong Lee,

  Affiliation College of Pharmacy, Inje University, Gimhae, Korea

  ⨯
• Irwin H. Gelman,

  Affiliation Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York, United States of America

  ⨯
• Ken Arai,

  Affiliation Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Eng H. Lo,

  Affiliation Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Kyu-Won Kim

  * E-mail: qwonkim@snu.ac.kr

  Affiliations SNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea, Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul National University, Seoul, Korea

  ⨯